EDIT (STOCKS)
Editas Medicine, Inc. Common Stock
$1.770000
-0.010000 (-0.56%)
Prev close: $1.780000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Gilmore O’Neill
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $173.76M
- Employees
- 226
- P/E (TTM)
- -0.74
- P/B (TTM)
- 12.27
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
8
Buy
6
Hold
2
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.28 | $-0.30 | +0.0222 | +7.35% |
|
Jun 2025 (Q2)
|
$-0.63 | $-0.38 | -0.2454 | -63.81% |
|
Mar 2025 (Q1)
|
$-0.92 | $-0.60 | -0.3191 | -53.10% |
|
Dec 2024 (Q4)
|
$-0.55 | $-0.36 | -0.1862 | -51.18% |
Financial Statements
| Revenues | $46.38M |
| Benefits Costs and Expenses | $0.00 |
| Costs And Expenses | $245.23M |
| Nonoperating Income/Loss | -$987.00K |
| Operating Expenses | $245.23M |
| Research and Development | $111.16M |
| Other Operating Expenses | $134.07M |
| Operating Income/Loss | -$198.85M |
| Income/Loss From Continuing Operations After Tax | -$199.84M |
| Income/Loss From Continuing Operations Before Tax | -$91.18M |
| Net Income/Loss | -$199.84M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$199.84M |
| Net Income/Loss Available To Common Stockholders, Basic | -$199.84M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.35 |
| Diluted Earnings Per Share | -$2.35 |
| Basic Average Shares | 257,650,204 |
| Diluted Average Shares | 85,970,866 |
| Assets | $201.75M |
| Current Assets | $176.89M |
| Accounts Receivable | $8.13M |
| Other Current Assets | $168.76M |
| Noncurrent Assets | $24.86M |
| Fixed Assets | $4.29M |
| Other Non-current Assets | $20.57M |
| Liabilities | $188.30M |
| Current Liabilities | $61.77M |
| Accounts Payable | $3.16M |
| Wages | $6.16M |
| Other Current Liabilities | $52.45M |
| Noncurrent Liabilities | $126.53M |
| Equity | $13.45M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $13.45M |
| Liabilities And Equity | $201.75M |
| Net Cash Flow From Operating Activities | -$179.62M |
| Net Cash Flow From Operating Activities, Continuing | -$179.62M |
| Net Cash Flow From Investing Activities | $169.57M |
| Net Cash Flow From Investing Activities, Continuing | $169.57M |
| Net Cash Flow From Financing Activities | $78.66M |
| Net Cash Flow From Financing Activities, Continuing | $78.66M |
| Net Cash Flow | $68.61M |
| Net Cash Flow, Continuing | $68.61M |
| Comprehensive Income/Loss | -$200.36M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$200.36M |
| Other Comprehensive Income/Loss | -$70.78M |